Bringing Cure...Building Hope...
Home | Blog | Events
Pharma legitimate consultant and facilitator in Delhi India

Oncology Drugs Approved For Multiple sclerosis by US FDA

IPN, New Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. IPN can facilitate patient to import of "Bladder Anti-Cancer Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Get Access to FDA Approved Drugs / Anti-Cancer Medicines
For Multiple sclerosis Treatment in India

A disease in which the immune system eats away at the protective covering of nerves. In MS, resulting nerve damage disrupts communication between the brain and the body. Multiple sclerosis causes many different symptoms, including vision loss, pain, fatigue and impaired coordination. The symptoms, severity and duration can vary from person to person. Some people may be symptom free for most of their lives, while others can have severe, chronic symptoms that never go away. Physiotherapy and medication that suppress the immune system can help with symptoms, and slow disease progression.

The following lists drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Multiple sclerosis treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

AVONEX

AVONEX (interferon beta-1a) injection. Initial U.S. Approval: 1996. Indications: AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.

More Details...
GILENYA

GILENYA (fingolimod) capsules. Oral medication. Initial U.S. Approval: 2010. Indications: GILENYA is used to treat multiple sclerosis-MS. It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord.

More Details...
AUBAGIO

AUBAGIO (teriflunomide) tablets for oral administration. Initial U.S. Approval: 2012. Indications: AUBAGIO is used by adults to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord.

More Details...
ZEPOSIA

ZEPOSIA (ozanimod) capsules, for oral use Initial U.S. Approval: 2020. Indications: ZEPOSIA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

More Details...
OCREVUS

OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017. Indications: OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults.

More Details...
TYSABRI

TYSABRI (natalizumab) injection, for intravenous use. Initial U.S. Approval: 2004. Indications: TYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML).

More Details...
CAMPATH

CAMPATH (alemtuzumab) Injection for intravenous use. Inital U.S. Approval: 2007. Indications: Alemtuzumab is used to treat a certain type of leukemia (B-cell chronic lymphocytic leukemia, also known as B-CLL). This medication works by slowing or stopping the growth of cancer cells.

More Details...
DENOPSY

DENOPSY (teriflunomide) tablets for oral administration. Initial U.S. Approval: 2012. Indications: Denopsy 14mg Tablet is a medicine used in the treatment of relapsing forms of multiple sclerosis (MS). It works by limiting the function of specific immune cells that cause nerve damage in multiple sclerosis. This way it prevents relapse as well as reduces the progression of the disease.

More Details...
FAMPYRA

FAMPYRA (fampridine) tablets. oral medication. Initial E.M.A Approval: 2011. Indications: Fampyra is a medicine used to improve walking ability in adults with multiple sclerosis (MS) who have a walking disability. MS is a disease of the nerves, in which inflammation destroys the protective sheath around the nerves. It contains the active substance fampridine.

More Details...
TECFIDERA

TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral use. Initial U.S. Approval: 2013. Indications: Tecfidera (dimethyl fumarate) is a brand-name prescription medication. It's used to treat relapsing forms of multiple sclerosis (MS). Tecfidera is classified as a disease-modifying therapy for MS. It reduces the risk of MS relapse by up to 49 percent over two years.

More Details...

Your Query Form

Head Office

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi, New Delhi:110016 India.

Mobile / WhatsApp Number:
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838 / 9811747774

Contact Details:
Phone: +91-11-26532129 / 26536398
Fax: +91-11-26532129 / 26536398

E Mail:
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Social Media:
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Multiple sclerosis medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Multiple sclerosis Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of Multiple sclerosis, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals.
Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Mumbai | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur | Punjab | Chandigarh
Our Overseas Network Uk | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa